KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 760,107 Value ($000) $14,997 Avg Close Range
Q4 2023
Shares 909,212 Value ($000) $15,948 Avg Close Range
Q3 2023
Shares 865,782 Value ($000) $15,039 Avg Close Range
Q2 2023
Shares 371,518 Value ($000) $5,231 Avg Close Range
Q1 2023
Shares 421,933 Value ($000) $4,540 Avg Close Range
Q4 2022
Shares 1,015,908 Value ($000) $15,218 Avg Close Range
Q3 2022
Shares 905,268 Value ($000) $12 Avg Close Range
Q2 2022
Shares 633,904 Value ($000) $6 Avg Close Range
Q1 2022
Shares 936,604 Value ($000) $9,310 Avg Close Range
Q4 2021
Shares 579,217 Value ($000) $6,817 Avg Close Range
Q3 2021
Shares 489,573 Value ($000) $5,576 Avg Close Range
Q2 2021
Shares 423,696 Value ($000) $5,902 Avg Close Range
Q1 2021
Shares 425,161 Value ($000) $7,869 Avg Close Range
Q4 2020
Shares 559,210 Value ($000) $9,881 Avg Close Range
Q3 2020
Shares 114,357 Value ($000) $1,752 Avg Close Range
Q2 2020
Shares 84,128 Value ($000) $2,144 Avg Close Range
Q1 2020
Shares 22,697 Value ($000) $351 Avg Close Range
Q4 2019
Shares 13,543 Value ($000) $150 Avg Close Range
Q3 2019
Shares 58,634 Value ($000) $499 Avg Close Range
Q2 2019
Shares 14,033 Value ($000) $190 Avg Close Range
Q1 2019
Shares 17,469 Value ($000) $315 Avg Close Range
Q2 2018
Shares 90,090 Value ($000) $1,563 Avg Close Range